Vocxi Health, Inc.

Overview

Vocxi Health introduces MyBreathPrint®, the innovative, noninvasive early disease detection system that delivers immediate, accurate results with just one minute of breathing: no needles, no radiation, no waiting.

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. In-Vitro Diagnostic Substance Manufacturing325413

Capabilities